ePrivacy and GPDR Cookie Consent by TermsFeed Generator

CITALOPRAM TEVA

20MG TBL FLM 30

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Interruption of marketing 05.10.2022 0106779, 0132688, 0132689, 0160303, 0164751, 0200883, 0230415, 0230417, 0230419, 0244390, 0244394, 0094948
Manufacturing reasons 30.11.2022
Resumption of marketing 22.08.2022
Interruption of marketing 31.12.2021 0106779, 0132688, 0132689, 0160303, 0164751, 0200875, 0230415, 0230417, 0230419, 0244394, 0094948
Capacity/distribution reasons 30.09.2022
Resumption of marketing 29.04.2020
Interruption of marketing 10.02.2020 0106779, 0114287, 0114292, 0132523, 0132524, 0132688, 0132689, 0160303, 0164751, 0200875, 0207220, 0230415, 0230417, 0094948
Manufacturing reasons 02/2020
Placing on the market 01.02.2010

All reports are available in the Overview.

Back to list